The WNT Inhibitor Dickkopf 1 and Bone Morphogenetic Protein 4 Rescue Adipogenesis in Hypertrophic Obesity in Humans

被引:114
|
作者
Gustafson, Birgit [1 ]
Smith, Ulf [1 ]
机构
[1] Univ Gothenburg, Lundberg Lab Diabet Res, Ctr Excellence Metab & Cardiovasc Res, Dept Mol & Clin Med,Sahlgrenska Acad, Gothenburg, Sweden
基金
瑞典研究理事会;
关键词
ADIPOCYTE LINEAGE; STEM-CELL; DIFFERENTIATION; ACCUMULATION; ANTAGONISTS; COMMITMENT; ACTIVATION; EXPRESSION; EXPANSION; ROLES;
D O I
10.2337/db11-1419
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Overweight characterized by inappropriate expansion of adipose cells (hypertrophic obesity) is associated with the metabolic syndrome and is caused by an inability to recruit and differentiate new precursor cells. We examined the role of bone morphogenetic protein 4 (BMP4) and WNT activation in the regulation of human adipose cell differentiation. Cluster of differentiation (CD) 14(+)/45(+) and CD31(+) cells were first removed before the remaining stromal vascular cells of human subcutaneous biopsy specimens were differentiated with/without different WNT inhibitors and/or BMP4. Inhibition of WNT and induction of Dickkopf 1 (DKK1) were markers of precursor cells undergoing excellent differentiation. The addition of Dial inhibited WNT activation and promoted adipogenesis in cells with a low degree of differentiation. The positive effect of DKK1, inhibiting cellular WNT activation by binding to the Kremen/LDL receptor-related protein receptors, was not seen with inhibitors of secreted WNT ligands. BMP4 increased differentiation, and BMP4 in the presence of DKK1 produced an additive effect. There was an apparent cross-talk between differentiation and commitment because BMP4 expression increased in differentiating adipocytes, and the addition of the BMP4 inhibitor, Noggin, reduced precursor cell differentiation. Thus, differentiated human adipose cells can promote adipogenesis via endogenous BMP4 activation, and the impaired adipogenesis in hypertrophic obesity is mainly due to an inability to suppress canonical WNT and to induce DKK1. Diabetes 61:1217-1224, 2012
引用
收藏
页码:1217 / 1224
页数:8
相关论文
共 49 条
  • [1] Restricted Adipogenesis in Hypertrophic Obesity The Role of WISP2, WNT, and BMP4
    Gustafson, Birgit
    Hammarstedt, Ann
    Hedjazifar, Shahram
    Smith, Ulf
    DIABETES, 2013, 62 (09) : 2997 - 3004
  • [2] MiR-503 inhibits adipogenesis by targeting bone morphogenetic protein receptor 1a
    Man, Xiao-Fei
    Tan, Shu-Wen
    Tang, Hao-Neng
    Guo, Yue
    Tang, Chen-Yi
    Tang, Jun
    Zhou, Ci-La
    Zhou, Hou-De
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (06): : 2727 - 2737
  • [3] The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases
    Mariz, Kasoha
    Ingolf, Juhasz-Boess
    Daniel, Herr
    Teresa, Ney Jasmin
    Erich-Franz, Solomayer
    CLINICAL & EXPERIMENTAL METASTASIS, 2015, 32 (08) : 857 - 866
  • [4] Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth
    Hover, Laura D.
    Young, Christian D.
    Bhola, Neil E.
    Wilson, Andrew J.
    Khabele, Dineo
    Hong, Charles C.
    Moses, Harold L.
    Owens, Philip
    CANCER LETTERS, 2015, 368 (01) : 79 - 87
  • [5] Suppression of tumorigenesis and activation of Wnt signaling by bone morphogenetic protein 4 in human cancer cells
    Nishanian, TG
    Kim, JS
    Foxworth, A
    Waldman, T
    CANCER BIOLOGY & THERAPY, 2004, 3 (07) : 667 - 675
  • [6] Bone Morphogenetic Protein 4 and Smad1 Mediate Extracellular Matrix Production in the Development of Diabetic Nephropathy
    Matsubara, Takeshi
    Araki, Makoto
    Abe, Hideharu
    Ueda, Otoya
    Jishage, Kou-ichi
    Mima, Akira
    Goto, Chisato
    Tominaga, Tatsuya
    Kinosaki, Masahiko
    Kishi, Seiji
    Nagai, Kojiro
    Iehara, Noriyuki
    Fukushima, Naoshi
    Kita, Toru
    Arai, Hidenori
    Doi, Toshio
    DIABETES, 2015, 64 (08) : 2978 - 2990
  • [7] Association of serum bone morphogenetic protein 4 levels with obesity and metabolic syndrome in non-diabetic individuals
    Son, Jang-Won
    Kim, Mee-Kyoung
    Park, Yong-Moon
    Baek, Ki-Hyun
    Yoo, Soon-Jib
    Song, Ki-Ho
    Son, Hyun Shik
    Yoon, Kun-Ho
    Lee, Won Chul
    Cha, Bong-Yun
    Son, Ho-Young
    Kwon, Hyuk-Sang
    ENDOCRINE JOURNAL, 2011, 58 (01) : 39 - 46
  • [8] Bone morphogenetic protein 1 prodomain specifically binds and regulates signaling by bone morphogenetic proteins 2 and 4
    Jasuja, Reema
    Ge, Gaoxiang
    Voss, Nikolas G.
    Lyman-Gingerich, Jamie
    Branam, Amanda M.
    Pelegri, Francisco J.
    Greenspan, Daniel S.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (12) : 9053 - 9062
  • [9] Effect of tumour necrosis factor-α inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity
    Korkosz, M.
    Gasowski, J.
    Leszczynski, P.
    Pawlak-Bus, K.
    Jeka, S.
    Siedlar, M.
    Grodzicki, T.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 (01) : 43 - 48
  • [10] New association of bone morphogenetic protein 4 concentrations with fat distribution in obesity and Exenatide intervention on it
    Wang, Xingchun
    Chen, Jiaqi
    Li, Liang
    Zhu, Cui Ling
    Gao, Jingyang
    Rampersad, Sharvan
    Bu, Le
    Qu, Shen
    LIPIDS IN HEALTH AND DISEASE, 2017, 16